Skip to main content

Your search for “clinical trials” returned 695 results

State’s Stem Cell Agency Awards $18.2 Million Grant for B Cell Cancer Clinical Trial

August 24, 2017

The Independent Citizens Oversight Committee of the California Institute for Regenerative Medicine (CIRM) today unanimously approved an $18.29 million grant to University of California San Diego School of Medicine researchers to fund a phase Ib/IIa clinical trial of a novel combination drug therapy for B-cell cancers.

Surgical Team Performs San Diego’s First HIV Donor to HIV Recipient Liver Transplant

September 3, 2020

UC San Diego Health is the first hospital in San Diego and only health care system in Southern California to transplant a liver from a donor with Human Immunodeficiency Virus (HIV) into an HIV-positive recipient. The surgery is part of a national clinical trial.

Will Anti-Arrhythmic Drug Beat Sudden Cardiac Arrest?

February 14, 2012

Sudden Cardiac Arrest (SCA) is the leading cause of death in the United States. This form of heart attack kills 325,000 people every year, representing one death every two minutes. Almost all SCA victims die before they even reach a hospital.

UC San Diego Selected to Lead International HIV/AIDS Clinical Trials Unit

November 30, 2020

University of California San Diego has been selected by the NIH to lead and administer an international seven-year, $28-million grant for HIV/AIDS clinical trials.

UC San Diego Researchers Launch Combination Drug Trial to Eradicate B-Cell Malignancies

March 9, 2018

…biotechnology company Oncternal Therapeutics, have launched a phase Ib/II clinical trial to evaluate the combined effectiveness of a standard of care drug with a novel monoclonal antibody that target B-cell malignancies, which include leukemias and lymphomas.

Clinical Trial Evaluates Synthetic Cannabinoid as Brain Cancer Treatment

September 25, 2012

Researchers at University of California, San Diego Moores Cancer Center are evaluating the safety and tolerability of a synthetic cannabinoid called dexanabinol (ETS2101). Delivered as a weekly intravenous infusion, the drug is being tested in patients with all forms of brain cancer, both primary and metastatic.

UC San Diego Joins National Trial to Test Drug for Treating MPOX

October 27, 2022

UC San Diego will be one of multiple sites assessing the safety and efficacy of tecovirimat as a potential treatment for human monkeypox. Marketed as TPOXX, tecovirimat is an antiviral currently approved for treatment of human smallpox in adults and children caused by the variola virus.

New Personalized Immunotherapy Trial Launched Despite COVID-19 Pandemic

December 10, 2020

…cancer. New Personalized Immunotherapy Trial Launched Despite COVID-19 Pandemic First patient to receive individualized TIL therapy undergoes treatment at Moores Cancer Center Since 2016, Bernard Thurman has undergone traditional treatments, experimental therapies and surgeries to counter the cancer within him, but nothing successfully eradicated the disease. Earlier this year, the…

UC San Diego Joins National Trial to Explore New Vaccines for COVID-19 Variants

April 6, 2022

UC San Diego has joined a Phase II clinical trial to evaluate various additional COVID-19 booster shots. The trial seeks to understand if different vaccine regimens can broaden immune responses in adults who already have received a primary vaccination series and a first booster shot.

At Bat Against Rare Blood Cancers

September 20, 2016

…that brings together the five UC health campuses conducting clinical studies for cancer patients. The consortium currently has four additional clinical trials planned for 2017.

Category navigation with Social links